Anti-Drug Antibodies Detected in the Presence of Adequate Infliximab Drug Levels In IBD Patients in Clinical Remission have Limited Clinical Significance

被引：0
|
作者：
Doherty, J. [1 ]
Varley, R. [1 ]
Healy, M. [2 ]
Dunne, C. [1 ]
Mac Carthy, F. [1 ]
McKiernan, S. [1 ]
Hartery, K. [1 ]
Kevans, D. [1 ]
机构：
[1] St James Hosp, Dept Gastroenterol, Dublin 8, Ireland
[2] St James Hosp, Dept Biochem, Dublin 8, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P408
引用
收藏
页码：S415 / S416
页数：3
相关论文
共 50 条
  • [31] Anti-drug Antibodies Inhibit Neutralization of TNF-alpha in Infliximab Treated Patients with Inflammatory Bowel Disease (IBD)
    Eser, A.
    Vogelsang, H.
    Reinisch, S.
    Novacek, G.
    Dejaco, C.
    Kazemi-Shirazi, L.
    Primas, C.
    Lichtenberger, C.
    Brehovsky, S.
    Singh, S.
    Jain, A.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S304 - S305
  • [32] Anti-drug Antibodies Monitoring in Biologics Use: Clinical Implications
    Dhahri, Rim
    Athimni, Selma
    Slouma, Maroua
    Metoui, Leila
    Gharsallah, Imene
    Louzir, Bassem
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (03) : 235 - 238
  • [33] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [34] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [35] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
    Ha, Christina
    Mathur, Jagrati
    Kornbluth, Asher
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
  • [36] THE EARLY INFLIXIMAB LEVELS MONITORING CAN PREDICT THE DEVELOPEMENT OF ANTI-DRUG ANTIBODIES IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Chamaida, P. -R.
    Pascual-Salcedo, D.
    Bonilla, M.
    Villalba, A.
    Lopez-Casla, M.
    Peiteado, D.
    Garcia-Carazo, S.
    Ramiro, S.
    Franco, K.
    Cajigas, D.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 157 - 157
  • [37] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [38] USEFULNESS OF MONITORING THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASES THROUGH THE DETERMINATION OF INFLIXIMAB OR ADALIMUMAB TROUGH LEVELS AND BY THE EVALUATION OF ANTI-DRUG ANTIBODIES
    Miranda, A.
    Sgambato, D.
    Ferrante, E.
    Picascia, D.
    Avallone, L.
    D'Amico, M.
    Sullo, M. G.
    Capuano, A.
    Romano, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E133 - E133
  • [39] Infliximab Assay Used in Clinical Practice Validated for Measuring SB2 Infliximab Biosimilar's Serum Drug and Anti-drug Antibody Levels
    Noguier, Guillaume
    Daviere, Simon
    Elouardani, Samia
    Veldet, Can
    Ticaud, Thierry
    Parussini, Ermis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S398 - S398
  • [40] Editorial: restoring therapeutic infliximab drug levels in patients with loss of response-pharmacokinetics and anti-drug antibodies as useful guidance tools
    Ben-Horin, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 845 - 846
12345